Cytochrome P450: Enzyme regulation and toxicological significance

Journal of Food and Drug Analysis

Volumn 4, Issue 1, 1996, Pages 18-23

  Ueng, Tzuu Huei ^a   Kang, Jaw Jou ^a   Chao, I Chi ^a   Chen, Yi Chien ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Cytochrome P450; Drug; Induction; Inhibition; Monooxygenase; Toxicity

Indexed keywords

EID: 3042990246     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Lu, A.Y.H. and West, S.B. 1980. Multiplicity of Mammalian Cytochromes P-450. Phamacol. Rev. 31: 277-296.
2. Alvares, A.P. 1981. Cytochrome P-450s: Research Highlights of the Last Two Decades. Drug Metab. Rev. 12: 431-436.
3. Coon, M.J., Ding, X. Pernecky, S.J. and Vaz, A.D.N. 1992. Cytochrome P450: Progress and Predictions. FASEB J. 6: 669-673.
4. Gonzalez, F.J. 1992. Human Cytochromes P450: Problems and Prospects. Trends Pharmacol. Sci. 13:346-352.
5. Guengerich, F.P. 1995. Influence of Nutrients and Other Dietary Materials on Cytochrome P-450 Enzymes. Am. J. Clin. Nutr. 61 (suppl.) : 651S-658S.
6. Ryan, D.E. and Levin, W. 1990. Purification and Characterization of Hepatic Microsomal Cytochrome P-450. Pharmac. Ther. 45: 153-239.
7. Nebert, D.W. 1994. Drug-Metabolizing Enzymes in Ligand-Modulated Transcription. Biochem. Pharmacol. 47: 25-37.
8. Porter, T.D. and Coon, M.J. 1991. Cytochrome P450. Multiplicity of Isoforms, Substrates, and Catalytic and Regulatory Mechanisms. J. Biol. Chem. 266: 13469-13472.
9. BM-3 and Other Inducible Bacterial P450 Cytochromes: Biochemistry and Regulation. Ann. Rev. Pharmacol. Toxicol. 31: 177-203.
10. Nelson, D.R., Kamataki, T., Waxman, D.J., Guengerich, F.P., Estabrook, R.W., Feyereisen, R., Gonzalez, F.J., Coon, M.J., Gunsalus, I.C., Gotoh, O., Okuda, K. and Nebert, D.W. 1993. The P450 Superfamily: Update on New Sequences, Gene Mapping, Accession Numbers, Early Trivial Names of Enzymes, and Nomenclature. DNA Cell Biol. 12: 1-51.
11. Alvares, A.P., Schilling, G., Levin, W. and Kuntzman, R. 1967. Studies on the Induction of CO-Binding Pigments in Liver Microsomes by Phenobarbital and 3-Methylcholanthrene. Biochem. Biophys. Res. Commun. 29: 521-526.
12. Ryan, D.E., Thomas, P.E., Korzenioski, D. and Levin, W. 1979. Separation and Characterization of Highly Purified Forms of Liver Microsomal Cytochrome P-450 from Rats Treated with Polychlorinated Biphenyls, Phenobarbital, and 3-Methylcholanthrene. J. Biol. Chem. 254: 1365-1374.
13. Guengerich, F.P. 1977. Separation and Purification of Multiple Forms of Microsomal Cytochromes P-450: Activities of Different Forms of Cytochromes P-450 towards Several Compounds of Environmental Interests. J. Biol. Chem. 252: 2970-3979.
14. Lu, A.Y.H. and Coon, M.J. 1968. Role of Hemoprotein P-450 in Fatty Acid ω-Hydroxylation System from Liver Microsomes. J. Biol. Chem. 243: 1331-1332.
15. Park, S.S., Fujino, T., West, D., Guengerich, F.P. and Gelboin, H.V. 1982. Monoclonal Antibodies Inhibiting Enzyme Activity of Cytochrome P-450 from 3-Methylcholanthrene-Treated Rats. Cancer Res. 42: 1798-1808.
16. Gelboin, H.V. 1993. Cytochrome P450 and Monoclonal Antibodies. Pharmacol. Rev. 45: 413-453.
17. Conney, A.M. 1982. Induction of Microsomal Enzymes by Foreign Chemicals and Carcinogenesis by Polycyclic Aromatic Hydrocarbons: G.H.A. Clowes Memorial Lecture. Cancer Res. 42: 4875-4917.
18. Whitlock, Jr. J.P. 1986. The Regulation of Cytochrome P-450 Gene Expression. Ann. Rev. Pharmacol. Toxicol. 26: 333-369.
19. Nebert, D.W. and Gonzalez, F.J. 1987. P450 Genes: Structure, Evolution, and Regulation. Ann. Rev. Biochem. 56: 945-993.
20. Gonzalez, F.J. 1989. The Molecular Biology of Cytochrome P450s. Pharmacol. Rev. 40: 243-288.
21. Okey, A.B. 1990. Enzyme Induction in the Cytochrome P-450 System. Pharmac. Ther. 45: 241-298.
22. Alvares, A.P. and Kappas, A. 1977. Heterogeneity of Cytochrome P-450s Induced by Polychlorinated Biphenyls. J. Biol. Chem. 252: 6373-6378.
23. Safe, S.H. 1994. Polychlorinated Biphenyls (PCBs): Environmental Impact, Biochemical and Toxic Responses, and Implications for Risk Assessment. Crit. Rev. Toxicol. 24: 87-149.
24. Guengerich, F.P. 1992. Metabolic Activation of Carcinogens. Pharmac. Ther. 54: 17-61.
25. Gonzalez, F.J. and Gelboin, H.V. 1994. Role of Human Cytochromes P450 in the Metabolic Activation of Chemical Carcinogens and Toxins. Drug Metab. Rev. 26: 165-183.
26. Gonzalez, F.J., Liu, S.-Y. and Yano, M. 1993. Regulation of Cytochrome P450 Genes: Molecular Mechanism. Pharmacogenetics 3: 51-57.
27. Koop, D.R., Crump, B.L., Nordblom, G.D. and Coon, M.J. 1985. Immunochemical Evidence for Induction of the Alcohol-oxidizing Cytochrome P-450 of Rabbit Liver Microsomes by Diverse Agents: Ethanol, Imidazole, Trichloroethylene, Acetone, Pyrazole, and Isoniazid. Proc. Natl. Acad. Sci. USA 82: 4065-4069.
28. Yang, C.S., Yoo, J.-S. H., Ishizaki, H. and Hong, J. 1990. Cytochrome P450IIE1: Roles in Nitrosamine Metabolism and Mechanisms of Regulation. Drug Metab. Rev. 22: 147-159.
29. Song, B.-J., Veech, R.L., Park, S.S., Gelboin, H.V. and Gonzalez, F.J. 1989. Induction of Rat Hepatic N-Nitrosodimethylamine Demethylase by Acetone is Due to Protein Stabilization. J. Biol. Chem. 264: 3568-3572.
30. Song, B.-J., Gelboin, H.V., Park, S.S., Yang, C.S. and Gonzalez, F.J. 1986. Complementary DNA and Protein Sequences of Ethanol-inducible Rat and Human Cytochrome P-450s. J. Biol. Chem. 261: 16689-16697.
31. Alvares, A.P. and Ueng, T.-H. 1987. Regulation of Pulmonary Cytochromes P-450 by Xenobiotics. In "Current Topics in Pulmonary Pharmacology and Toxicology" Vol. 2, pp. 136-159. Hollinger M.A. (ed) Elsevier, New York, U.S.A.
32. Ueng, T.-H., Eiseman, J.-L. and Alvares, A.P. 1980. Inhibition of Pulmonary Cytochrome P-450 and Benzo(a)pyrene Hydroxylase in Rabbits by Polychlorinated Biphenyls. Biochem. Biophys. Res. Commun. 95: 1743-1749.
33. Ueng, T.-H. and Alvares, A.P. 1981. Selective Loss of Pulmonary Cytochrome P-450I in Rabbits Pretreated with Polychlorinated Biphenyls. J. Biol. Chem. 256: 7536-7542.
34. Ueng, T.-H. and Alvares, A.P. 1985. Selective Induction and Inhibition of Liver and Lung Cytochrome P-450-Dependent Monooxygenases by the PCBs Mixture, Aroclor 1016. Toxicology. 35: 83-94.
35. Johansson, I., Ekstrom, G., Scholte, B., Puzycki, D., Jornvall, H. and Ingelman-Sundberg, M. 1988. Ethanol-, Fasting-, and Acetone-inducible Cytochromes P-450 in Rat Liver: Regulation and Characteristics of Enzymes Belonging to the IIB and IIE Gene Subfamilies. Biochemistry 27: 1925-1934.
36. Porter, T.D., Khani, S. and Coon, M.J. 1989. Induction and Tissue-specific Expression of Rabbit Cytochrome P450IIE1 and IIE2 Genes. Mol. Pharmacol. 89: 61-65.
37. Ueng, T.-H., Friedman, F.K., Miller, H., Park, S.S., Gelboin, H.V. and Alvares, A.P. 1987. Studies on Ethanol-inducible Cytochrome P-450 in Rabbit Liver, Lungs and Kidneys. Biochem. Pharmacol. 36: 2689-2691.
38. Ueng, T.-H., Ueng, Y.-F., Tsai, J.-N., Chao, I.-C, Chen, T.-L., Park, S.S., Iwasaki, M. and Guengerich, F.P. 1993. Induction and Inhibition of Cytochrome P-450-dependent Monooxygenases in Hamster Tissues by Ethanol. Toxicology. 81: 145-154.
39. Ortiz de Montellano, P.R. and Reich, N.O. 1986. Inhibition of Cytochrome P-450 Enzymes. In "Cytochrome P-450" pp. 273-314. Ortiz de Montellano, P.R. (ed) Plenum Publishing, New York, U.S.A.
40. Murray, M. 1987. Mechanism of the Inhibition of Cytochrome P-450-mediated Drug Oxidation by Therapeutic Agents. Drug Metab. Rev. 18: 55-81.
41. Testa, B. 1990. Mechanisms of Inhibition of Xenobiotic-metabolizing Enzymes. Xenobiotica. 20: 1129-1137.
42. Halpert, J.R., Guengerich, F.P., Bend, J.R. and Correia, M.A. 1994. Selective Inhibitors of Cytochromes P450. Toxicol. Appl. Pharmacol. 125: 163-175.
43. Nebert, D.W. 1991. Role of Genetics and Drug Metabolism in Human Cancer Risk. Mutat. Res. 247: 267-281.
44. Kadlubar, F.F. 1994. Biochemical Individuality and its Implications for Drug and Carcinogen Metabolism: Recent Insights from Acetyltransferase and Cytochrome P4501A2 Phenotyping and Genotyping in Humans. Drug Metab. Rev. 26: 37-46.
45. Kaname, K., Kei, N., Kazue, I., Akira, Y., Nahomi, S. and Junko, W. 1990. Identification of Genetically High Risk Individuals to Lung Cancer by DNA Polymorphisms of the Cytochrome P4501A1 Gene. FEBS Lett. 263: 131-133.
46. Kato, S., Shield, P.G., Caporaso, N.E., Sugimura, H., Trivers, G.E, Tucker, M.A., Trump, B.F., Weston, A. and Harris, C.C. 1994. Analysis of Cytochrome P450 2E1 Genetic Polymorphisms in Relation to Human Lung Cancer. Cancer Epidemiol. Biomarkers Prev. 1: 485-489.
47. Meyer, U.A. 1990. Genetic Polymorphisms of Drug Metabolism. Fund. Clin. Pharmacol. 4: 595-615.
48. C18 Gene(CYP11B2) in CMO II Deficient Patients. Biochem. Biophys. Res. Commun. 182:974-979.
49. Wang, S.-L., Huang, J.-D., Lai, M.-D., Liu, B.-H. and Lai, M.-L. 1993. Molecular Basis of Genetic Variation in Debrisoquin Hydroxylation in Chinese Subjects: Polymorphism in RFLP and DNA Sequences of CYP2D6. Clin. Pharmacol. Ther. 53: 410-418.
50. Kawajiri, K., Nakachi, K., Watanabe, J. and Hayashi, S. 1993. The CYP1A1 Gene and Cancer Susceptibility. Crit. Rev. Oncol. Hematol. 14: 77-87.
51. Cosma, G., Crofts, F., Taioli, E., Toniolo, P. and Garte, S. 1993. Relationship between Genotype and Function of the Human CYP1A1 Gene. J. Toxicol. Environ. Hlth. 40: 309-316.
52. Shields, P.G., Caporso, N.E., Falk, R.T., Sugimura, H., Trivers, G.E., Trump, B.F., Hoover, R.N., Weston, A. and Harris, C.C. 1993. Lung Cancer, Race and a CYP1A1 Genetic Polymorphism. Cancer Epidemiol. Biomarkers Prev. 2: 481-485.
53. Gonzalez, F.J., Crespi, C.L. and Gelboin, H.V. 1991. cDNA-Expressed Human Cytochrome P450s: a New Age of Molecular Toxicology and Human Risk Assessment. Mutat. Res. 247: 113-127.
54. Langenbach, R., Smith, P.B. and Crespi, C. 1992. Recombinant DNA Approaches for the Development of Metabolic Systems Used in In Vitro Toxicology. Mutat. Res. 277: 251-275.
55. Crespi, C., Langenbach, R. and Penman, B.W. 1993. Human Cell Lines, Derived from AHH-1 TK+/- Human Lympohblasts, Genetically Engineered for Expression of Cytochromes P450. Toxicology. 89: 89-104.
56. Johnson, E.F., Kronbach, T. and Hsu, M.-H. 1992. Analysis of the Catalytic Specificity of Cytochrome P450 Enzymes through Site-Directed Mutagenesis. FEBS J. 6: 700-705.
57. 2+ Influx. Biochem. J. 274: 193-197.
58. 2+ Stores. FASEB J. 6: 786-792.
59. Aussel, C., Breittmayer, J.P., Ticchioni, M., Pelassy, C. and Bernard, A. 1994. Regulation of T Cell Activation by Cytochrome P450 Inhibitors. Cellular Immun. 155: 436-445.
60. 2+ Entry in Human and Bovine Endothelial Cells. J. Physiol. 482: 259-274.
61. Lu, G.-T. 1991. Effects of Some Compounds Isolated from Chinese Medicinal Herbs on Hepatic Micrsomal Cytochrome P-450 and their Potential Biological Consequences. Drug Metab. Rev. 23: 439-465.
62. Wang, B.Y.Y., Lau, B.H.S., Yamasaki, T. and Teel, R.W. 1993. Modulation of Cytochrome P450IA1-Mediated Mutagenicity, DNA Binding and Metabolism of Benzo[a]pyrene by Chinese Medicinal Herbs. Cancer Lett. 68: 75-68.
63. Liu, X.-F., Liu, M.-L., Iyanagi, T., Legesse, K., Lee, T.D. and Chen, S. 1990. Inhibition of Rat Liver NAD(P)H:Quinone Acceptor Oxidoreductase (DT-Diaphorase) by Flavonoids Isolated from the Chinese Herb Scutellariae Radix (Huang Qin). Mol. Pharmacol. 37: 911-915.
64. Kang, J.-J., Chen, Y.-C., Kuo, W.-C., Chen, T., Cheng, Y.-W., Kuo, M.L. and Ueng, T.-H. Modulation of Microsomal Cytochrome P450 by Scutellariae Radix and Gentianae Scabre Radix in Rat Liver. Am. J. Chin. Med. in press.